暗記メーカー

暗記メーカー

​
ログイン
barbiturates
26問 • 1年前
  • Hannah Angelique Losaria
    • 通報

    問題一覧

  • 1

    major toxic manifestations of barbiturate poisoning

    CNS and cardiovascular (CV) depress

  • 2

    acts directly on the chemoreceptor trigger zone to induce emesis

    apomorphine

  • 3

    is a non-benzodiazepine hypnotic of the imidazopyridine class. Pharmacologically, it interacts with the GABA–BZ receptor complex and shares some pharmacological properties of BZs.

    zolpidem

  • 4

    an antianxiety agent that is not chemically or pharmacologically related to the BZs, barbiturates, or other S/H drugs. It does not exert anticonvulsant or muscle relaxant effects, nor does it interact with GABA receptors.

    buspirone

  • 5

    -used internationally in the treatment of insomnia as well as a preanesthetic benzodiazepine, it is a U.S. federal schedule I controlled substance with no legitimate therapeutic or prescribing uses. -used as a “date-rape” drug because of its intoxicating and amnestic effects. * The agent causes euphoria, hallucinations, and disinhibiting effects and has also been used to enhance heroin and cocaine euphoria.

    flunitrazepam

  • 6

    has been promoted and abused for sleep disorders (narcolepsy), as an anesthetic agent, as treatment for alcohol and controlled substance withdrawal, and currently, as an inducer of growth hormone (bodybuilding), and aphrodisiac. The tasteless, odorless, liquid or gel form makes it convenient for use as a “date-rape” drug.

  • 7

    is a pure opioid antagonist available as an injectable only.

    naloxone

  • 8

    is also a pure opioid antagonist available as an oral tablet dosage form only.

    naltrexone

  • 9

    available in 100 μg/ml and 1 mg/ml ampoules, is indicated for the complete or partial reversal of natural or synthetic opioid effects.

    nalmefene

  • 10

    is a potent analgesic with narcotic agonist and antagonist actions.

    nalbuphine

  • 11

    involves compulsive psychoactive drug use with an overwhelming involvement in the securing and using of such drugs.

    addiction

  • 12

    occurs as a result of sudden or abrupt discontinuation of the substance.

    withdrawal syndrome

  • 13

    use involves the psychological need to procure and use drugs, often referred to as craving.

    compulsive drugs

  • 14

    refers to psychological dependence.

    habituation

  • 15

    involves the need for repeated administration to prevent withdrawal (abstinence) syndrome. I

    physical/ physiological dependence

  • 16

    -with repeated administration, addicted individuals require greater amounts of drug to achieve the desired effect. Conversely, the euphoric effect is markedly diminished with continued use of the same amount of drug.

    tolerance

  • 17

    is the first opioid drug for the treatment of opioid dependence in an officebased setting. The drug, a partial opioid agonist, is dispensed for outpatient use and administered sublingually, sometimes in combination with naloxone, the full opioid antagonist.

    buprenorphine

  • 18

    (methylmorphine) is available in combination with other ingredients as an analgesic (Tylenol with ______®) and as an antitussive in prescription cough, cold, antihistaminic, and expectorant formulas.

    codeine

  • 19

    A synthetic opiate chemically related to meperidine, diphenoxylate is combined with atropine (Lomotil®) for the treatment of diarrhea.

    diphenoxylate

  • 20

    marketed in the form of medicated patches (Duragesic Transdermal System®) for the management of chronic pain.

    fentanyl

  • 21

    The first synthetic opioid (1939), ________ is equianalgesic with morphine.

    meperidine

  • 22

    is a benzomorphan derivative of morphine with three to four times its analgesic potency and the same addictive potential.

    pentazocine

  • 23

    A methadone analog, ________ is implicated in cardiotoxicity. ___________ is frequently used as the napsylate salt in combination with acetaminophen (Darvocet-N®).

    propoxyphene

  • 24

    are powerful μ- receptor agonists with addictive and analgesic potential equivalent to those of morphine and heroin, respectively.

    Hydrocodone/oxycodone

  • 25

    is a centrally acting synthetic analog of codeine with low affinity for the μ-receptor. It is used for moderate to severe pain control.

    tramadol

  • 26

    primarily stimulates central postsynaptic α2- receptors that inhibit neuronal activity and decrease sympathetic overtone.

    clonidine

    • gastro

    gastro

    Hannah Angelique Losaria · 100問 · 2年前

    gastro

    gastro

    100問 • 2年前
    Hannah Angelique Losaria

    gastro m

    gastro m

    Hannah Angelique Losaria · 7問 · 2年前

    gastro m

    gastro m

    7問 • 2年前
    Hannah Angelique Losaria

    lab

    lab

    Hannah Angelique Losaria · 13問 · 2年前

    lab

    lab

    13問 • 2年前
    Hannah Angelique Losaria

    m2

    m2

    Hannah Angelique Losaria · 94問 · 2年前

    m2

    m2

    94問 • 2年前
    Hannah Angelique Losaria

    m1

    m1

    Hannah Angelique Losaria · 88問 · 2年前

    m1

    m1

    88問 • 2年前
    Hannah Angelique Losaria

    poisons

    poisons

    Hannah Angelique Losaria · 50問 · 1年前

    poisons

    poisons

    50問 • 1年前
    Hannah Angelique Losaria

    lec

    lec

    Hannah Angelique Losaria · 19問 · 1年前

    lec

    lec

    19問 • 1年前
    Hannah Angelique Losaria

    exam

    exam

    Hannah Angelique Losaria · 16問 · 1年前

    exam

    exam

    16問 • 1年前
    Hannah Angelique Losaria

    spec

    spec

    Hannah Angelique Losaria · 41問 · 1年前

    spec

    spec

    41問 • 1年前
    Hannah Angelique Losaria

    midterm

    midterm

    Hannah Angelique Losaria · 55問 · 1年前

    midterm

    midterm

    55問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    Hannah Angelique Losaria · 54問 · 1年前

    PHYSICAL PHARMACY

    PHYSICAL PHARMACY

    54問 • 1年前
    Hannah Angelique Losaria

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    Hannah Angelique Losaria · 29問 · 1年前

    PHYSICAL PHARMACY II

    PHYSICAL PHARMACY II

    29問 • 1年前
    Hannah Angelique Losaria

    DDS

    DDS

    Hannah Angelique Losaria · 33問 · 1年前

    DDS

    DDS

    33問 • 1年前
    Hannah Angelique Losaria

    hallucinogens

    hallucinogens

    Hannah Angelique Losaria · 22問 · 1年前

    hallucinogens

    hallucinogens

    22問 • 1年前
    Hannah Angelique Losaria

    non volatile poisons

    non volatile poisons

    Hannah Angelique Losaria · 42問 · 1年前

    non volatile poisons

    non volatile poisons

    42問 • 1年前
    Hannah Angelique Losaria

    endterm

    endterm

    Hannah Angelique Losaria · 63問 · 1年前

    endterm

    endterm

    63問 • 1年前
    Hannah Angelique Losaria

    q3 endterm

    q3 endterm

    Hannah Angelique Losaria · 17問 · 1年前

    q3 endterm

    q3 endterm

    17問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019

    mockboard 2019

    Hannah Angelique Losaria · 65問 · 1年前

    mockboard 2019

    mockboard 2019

    65問 • 1年前
    Hannah Angelique Losaria

    mockboard 2019 II

    mockboard 2019 II

    Hannah Angelique Losaria · 39問 · 1年前

    mockboard 2019 II

    mockboard 2019 II

    39問 • 1年前
    Hannah Angelique Losaria

    問題一覧

  • 1

    major toxic manifestations of barbiturate poisoning

    CNS and cardiovascular (CV) depress

  • 2

    acts directly on the chemoreceptor trigger zone to induce emesis

    apomorphine

  • 3

    is a non-benzodiazepine hypnotic of the imidazopyridine class. Pharmacologically, it interacts with the GABA–BZ receptor complex and shares some pharmacological properties of BZs.

    zolpidem

  • 4

    an antianxiety agent that is not chemically or pharmacologically related to the BZs, barbiturates, or other S/H drugs. It does not exert anticonvulsant or muscle relaxant effects, nor does it interact with GABA receptors.

    buspirone

  • 5

    -used internationally in the treatment of insomnia as well as a preanesthetic benzodiazepine, it is a U.S. federal schedule I controlled substance with no legitimate therapeutic or prescribing uses. -used as a “date-rape” drug because of its intoxicating and amnestic effects. * The agent causes euphoria, hallucinations, and disinhibiting effects and has also been used to enhance heroin and cocaine euphoria.

    flunitrazepam

  • 6

    has been promoted and abused for sleep disorders (narcolepsy), as an anesthetic agent, as treatment for alcohol and controlled substance withdrawal, and currently, as an inducer of growth hormone (bodybuilding), and aphrodisiac. The tasteless, odorless, liquid or gel form makes it convenient for use as a “date-rape” drug.

  • 7

    is a pure opioid antagonist available as an injectable only.

    naloxone

  • 8

    is also a pure opioid antagonist available as an oral tablet dosage form only.

    naltrexone

  • 9

    available in 100 μg/ml and 1 mg/ml ampoules, is indicated for the complete or partial reversal of natural or synthetic opioid effects.

    nalmefene

  • 10

    is a potent analgesic with narcotic agonist and antagonist actions.

    nalbuphine

  • 11

    involves compulsive psychoactive drug use with an overwhelming involvement in the securing and using of such drugs.

    addiction

  • 12

    occurs as a result of sudden or abrupt discontinuation of the substance.

    withdrawal syndrome

  • 13

    use involves the psychological need to procure and use drugs, often referred to as craving.

    compulsive drugs

  • 14

    refers to psychological dependence.

    habituation

  • 15

    involves the need for repeated administration to prevent withdrawal (abstinence) syndrome. I

    physical/ physiological dependence

  • 16

    -with repeated administration, addicted individuals require greater amounts of drug to achieve the desired effect. Conversely, the euphoric effect is markedly diminished with continued use of the same amount of drug.

    tolerance

  • 17

    is the first opioid drug for the treatment of opioid dependence in an officebased setting. The drug, a partial opioid agonist, is dispensed for outpatient use and administered sublingually, sometimes in combination with naloxone, the full opioid antagonist.

    buprenorphine

  • 18

    (methylmorphine) is available in combination with other ingredients as an analgesic (Tylenol with ______®) and as an antitussive in prescription cough, cold, antihistaminic, and expectorant formulas.

    codeine

  • 19

    A synthetic opiate chemically related to meperidine, diphenoxylate is combined with atropine (Lomotil®) for the treatment of diarrhea.

    diphenoxylate

  • 20

    marketed in the form of medicated patches (Duragesic Transdermal System®) for the management of chronic pain.

    fentanyl

  • 21

    The first synthetic opioid (1939), ________ is equianalgesic with morphine.

    meperidine

  • 22

    is a benzomorphan derivative of morphine with three to four times its analgesic potency and the same addictive potential.

    pentazocine

  • 23

    A methadone analog, ________ is implicated in cardiotoxicity. ___________ is frequently used as the napsylate salt in combination with acetaminophen (Darvocet-N®).

    propoxyphene

  • 24

    are powerful μ- receptor agonists with addictive and analgesic potential equivalent to those of morphine and heroin, respectively.

    Hydrocodone/oxycodone

  • 25

    is a centrally acting synthetic analog of codeine with low affinity for the μ-receptor. It is used for moderate to severe pain control.

    tramadol

  • 26

    primarily stimulates central postsynaptic α2- receptors that inhibit neuronal activity and decrease sympathetic overtone.

    clonidine